Patents by Inventor Michael Siddiqui

Michael Siddiqui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKER
    Publication number: 20250052738
    Abstract: The invention relates to a method of diagnosing and a method of treating a cardiorespiratory disease in a subject.
    Type: Application
    Filed: July 19, 2022
    Publication date: February 13, 2025
    Inventors: Christopher BRIGHTLING, Salman SIDDIQUI, Rebecca Lynne CORDELL, Michael John WILDE
  • Method for producing objective substance
    Patent number: 10883124
    Abstract: A method for producing an objective substance such as vanillin and vanillic acid is provided. An objective substance is produced from a carbon source or a precursor of the objective substance by using a microorganism having an objective substance-producing ability, which microorganism has been modified to have a Bacteroidetes O-methyltransferase (OMT) gene, especially an OMT gene encoding OMT having a specific mutation.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: January 5, 2021
    Assignee: AJINOMOTO CO., INC.
    Inventors: Benjamin Mijts, Sheetal Modi, Michael Siddiqui, Christine Roche
  • Method for Producing Objective Substance
    Publication number: 20190249204
    Abstract: A method for producing an objective substance such as vanillin and vanillic acid is provided. An objective substance is produced from a carbon source or a precursor of the objective substance by using a microorganism having an objective substance-producing ability, which microorganism has been modified to have a Bacteroidetes O-methyltransferase (OMT) gene, especially an OMT gene encoding OMT having a specific mutation.
    Type: Application
    Filed: April 24, 2019
    Publication date: August 15, 2019
    Applicant: AJINOMOTO CO., INC.
    Inventors: Benjamin Mijts, Sheetal Modi, Michael Siddiqui, Christine Roche